aycan introduces ayDCE - software for more accurate, efficient prostate MRI evaluations

Rochester, NY, February 13, 2017.  aycan, a recognized global leader in medical imaging, introduced ayDCE software powered by aycan workstation.  The new software helps expedite the review and documentation of mpMRI scans, which have been rising in usage to detect carcinomas in prostrates and other areas.

ayDCE helps urology and radiology specialists to easily evaluate and document dynamic contrasts shown in mpMRI scans up to 70% faster than with traditional methods, generating structured reports with key images for sharing with colleagues and patients.

Key capabilities of ayDCE include a structured report template for easy calculation of PI-RADS score; integration of key images into structured reports; evaluation of dynamic MRI/CT examinations; Individual Hanging Protocols; representation of contrast medium dynamics; color superposition of semi-quantitative parameters; and structured findings.

aycan workstation is an FDA 510(k) cleared, vendor-neutral, highly functional advanced image-processing tool and DICOM PACS workstation for conventional, multi-slice and other image reading.

ABOUT aycan
With a focus on vendor neutral integration and service, aycan is a leading global provider of solutions for viewing, printing, sharing, and storing medical images and information that improve workflow efficiency and drive down costs.  aycan works with other industry innovators such as Xerox and Apple, whose quality products are part of their solutions.  all aycan solutions are developed in full compliance with FDA Regulatory Affairs and using a quality management system that strictly follows ISO regulations, such as ISO 13485, which sets the highest safety standard for medical product development. aycan supports worldwide customers with U.S. headquarters in Rochester, New York, and European headquarters in Wuerzburg Germany. The company is privately held.

Around the web

The two companies aim to improve patient access to high-quality MRI scans by combining their artificial intelligence capabilities.

Positron, a New York-based nuclear imaging company, will now provide Upbeat Cardiology Solutions with advanced PET/CT systems and services. 

The nuclear imaging isotope shortage of molybdenum-99 may be over now that the sidelined reactor is restarting. ASNC's president says PET and new SPECT technologies helped cardiac imaging labs better weather the storm.